Literature DB >> 18719919

A case of limited systemic sclerosis with p-ANCA, complicated by multiple cerebral hemorrhages.

Bharath Manu Akkara Veetil1, Barry M Schimmer.   

Abstract

ANCA associated vasculitides are a group of disorders characterized by the presence of necrotizing inflammation of blood vessels that involve venules, capillaries, arterioles, arteries, and veins. They are characterized by the presence of antineutrophil cytoplasmic antibodies (ANCA). ANCA associated vasculitis commonly affects the kidney producing proteinuria, hematuria and variable degrees of renal failure. Other organs involved include the lung, skin and peripheral nervous system. We present a patient with limited systemic sclerosis, who later developed pauci-immune glomerulonephritis with p-ANCA (antimyeloperoxidase) specificity and, whose disease was later complicated by cerebral vasculitis with multiple intracerebral hemorrhages.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18719919     DOI: 10.1007/s00296-008-0675-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  20 in total

Review 1.  Microscopic polyangiitis (microscopic polyarteritis).

Authors:  J C Jennette; D B Thomas; R J Falk
Journal:  Semin Diagn Pathol       Date:  2001-02       Impact factor: 3.464

2.  Microscopic polyarteritis with renal and cerebral involvement.

Authors:  P V Deshpande; R Gilbert; H Alton; D V Milford
Journal:  Pediatr Nephrol       Date:  2000-11       Impact factor: 3.714

3.  A case of ANCA-associated vasculitis with predominant involvement of central nervous system.

Authors:  P Caramaschi; D Biasi; A Carletto; L M Bambara
Journal:  Joint Bone Spine       Date:  2003-09       Impact factor: 4.929

Review 4.  ANCA are pathogenic--oh yes they are!

Authors:  Ronald J Falk; J Charles Jennette
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121

5.  Microscopic polyangitis presenting with sub-acute reversible optic neuropathy.

Authors:  R Altaie; F Ditizio; G T Fahy
Journal:  Eye (Lond)       Date:  2005-03       Impact factor: 3.775

6.  Antineutrophil cytoplasmic autoantibody-associated diseases: a pathologist's perspective.

Authors:  J C Jennette
Journal:  Am J Kidney Dis       Date:  1991-08       Impact factor: 8.860

Review 7.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

8.  Autoantibodies to myeloperoxidase in systemic sclerosis.

Authors:  I C Locke; J G Worrall; B Leaker; C M Black; G Cambridge
Journal:  J Rheumatol       Date:  1997-01       Impact factor: 4.666

9.  Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.

Authors:  P H Nachman; S L Hogan; J C Jennette; R J Falk
Journal:  J Am Soc Nephrol       Date:  1996-01       Impact factor: 10.121

10.  Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis.

Authors:  H Endo; T Hosono; H Kondo
Journal:  J Rheumatol       Date:  1994-05       Impact factor: 4.666

View more
  4 in total

1.  Development of intracerebral hemorrhage in the short-term clinical course of a patient with microscopic polyangiitis without neurological symptoms at diagnosis: an autopsy case.

Authors:  Yoshia Miyawaki; Takayuki Katsuyama; Ken-Ei Sada; Kohei Taniguchi; Yuki Kakio; Jun Wada
Journal:  CEN Case Rep       Date:  2016-04-05

2.  Risk of bleeding events among patients with systemic sclerosis and the general population in the UK: a large population-based cohort study.

Authors:  Alexander Michel; Antonio González-Pérez; María E Sáez; Luis A García Rodríguez
Journal:  Clin Rheumatol       Date:  2019-05-14       Impact factor: 2.980

3.  Vasculitis in systemic sclerosis.

Authors:  Lily Kao; Cornelia Weyand
Journal:  Int J Rheumatol       Date:  2010-09-30

4.  Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis.

Authors:  Jayne Moxey; Molla Huq; Susanna Proudman; Joanne Sahhar; Gene-Siew Ngian; Jenny Walker; Gemma Strickland; Michelle Wilson; Laura Ross; Gabor Major; Janet Roddy; Wendy Stevens; Mandana Nikpour
Journal:  Arthritis Res Ther       Date:  2019-02-14       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.